SB 415 Public Health Essential Generic Drugs Price Gouging Prohibition
Maryland 2017 Regular Session
Public Health - Essential Generic Drugs - Price Gouging - Prohibition
SB-415
About SB-415
Prohibiting a manufacturer or wholesale distributor from engaging in price gouging in the sale of an essential generic drug; requiring the Maryland Medical Assistance Program to notify the manufacturer of an essential generic drug and the Attorney General of a specified increase in the price of the essential generic drug under specified circumstances; requiring a manufacturer of an essential generic drug to submit a specified statement to the Attorney General within 20 days after receipt of a specified notice; etc.
Bill Texts
Introduced 01/27/2017
Weigh In
No votes yet!
Cast yours now to be the first.
Votes for: 0 Votes against: 0
Spread the Word!
Gettr
Sponsors (24)
